MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 16 April 2007 - PuriCore (LSE: PURI), the life sciences company focused on the development and commercialisation of its novel, safe antimicrobial technology, today announces its inaugural annual results for the year ended 31 December 2006.
